What does PHARMACIE GONAY do?

PHARMACIE GONAY is a pharmacy in Liège. Private Limited, started on 21 December 2007, 1 establishment.

What is the address of PHARMACIE GONAY?

The registered office of PHARMACIE GONAY is located at Rue du Parc 5, 4020 Liège.

Is PHARMACIE GONAY still active?

Yes. According to the CBE (4 October 2026) PHARMACIE GONAY is active, legal situation “Normale toestand”, started on 21 December 2007.

Is PHARMACIE GONAY registered on Peppol?

Yes, PHARMACIE GONAY is registered on the Peppol network with ID 0208:0894414729.

What is the enterprise number of PHARMACIE GONAY?

The enterprise number of PHARMACIE GONAY is BE0894414729.

When was PHARMACIE GONAY founded?

PHARMACIE GONAY was founded on 21 December 2007.

Who are the directors of PHARMACIE GONAY?

According to the 2025 annual accounts, the directors of PHARMACIE GONAY are: Sophie GONAY.

Is PHARMACIE GONAY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 December 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE GONAY make in 2025?

PHARMACIE GONAY posted a profit after taxes of € 3,335 in financial year 2025.

What is the revenue of PHARMACIE GONAY?

As a small company, PHARMACIE GONAY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 79,008.

PHARMACIE GONAY (Private Limited) - Liège - BE0894414729

Dossier PHARMACIE GONAY, printed on 4 October 2026 from databakkes.be/en/0894414729/pharmacie-gonay. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 50 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE GONAY from Liège, company number BE0894414729, closed financial year 2025 with a result of € 3,335 after tax. For that financial year PHARMACIE GONAY recorded a gross margin of € 79,008 and equity of € 65,535. Compared with financial year 2024, the result moved from € -15,240 to € 3,335. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Growing

€ 65,535

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 3,335

▲ still € 15,240 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 735

▼ 93% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 46,935.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 54,441

▲ 3% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,527

▼ 45% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 159,876

▼ 14% vs 2024

€ 16,406 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 19,915

▼ 59% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 14,593

▼ 16% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 64,618 Gross margin 2022: € 64,618 First fiscal year in the series	€ 82,724 Gross margin 2023: € 82,724 ▲ 28% vs 2022 (€ 64,618) Favourable step	€ 57,731 Gross margin 2024: € 57,731 ▼ 30% vs 2023 (€ 82,724) Unfavourable step	€ 79,008 Gross margin 2025: € 79,008 ▲ 37% vs 2024 (€ 57,731) Favourable step	▲ 37%
Profit after taxes	€ 3,290 Profit after taxes 2022: € 3,290 First fiscal year in the series	€ 7,019 Profit after taxes 2023: € 7,019 ▲ 113% vs 2022 (€ 3,290) Favourable step	€ -15,240 Profit after taxes 2024: € -15,240 ▼ € 22,259 vs 2023 (€ 7,019) Unfavourable step	€ 3,335 Profit after taxes 2025: € 3,335 ▲ € 18,575 vs 2024 (€ -15,240) Favourable step	▲ € 18,575
Equity	€ 71,255 Equity 2022: € 71,255 First fiscal year in the series	€ 77,441 Equity 2023: € 77,441 ▲ 9% vs 2022 (€ 71,255) Favourable step	€ 62,200 Equity 2024: € 62,200 ▼ 20% vs 2023 (€ 77,441) Unfavourable step	€ 65,535 Equity 2025: € 65,535 ▲ 5% vs 2024 (€ 62,200) Favourable step	▲ 5%
Total debts	€ 250,383 Total debts 2022: € 250,383 First fiscal year in the series	€ 236,855 Total debts 2023: € 236,855 ▼ 5% vs 2022 (€ 250,383) Favourable step	€ 252,657 Total debts 2024: € 252,657 ▲ 7% vs 2023 (€ 236,855) Unfavourable step	€ 195,218 Total debts 2025: € 195,218 ▼ 23% vs 2024 (€ 252,657) Favourable step	▼ 23%
Cash	€ 21,126 Cash 2022: € 21,126 First fiscal year in the series	€ 8,355 Cash 2023: € 8,355 ▼ 60% vs 2022 (€ 21,126) Unfavourable step	€ 11,093 Cash 2024: € 11,093 ▲ 33% vs 2023 (€ 8,355) Favourable step	€ 735 Cash 2025: € 735 ▼ 93% vs 2024 (€ 11,093) Unfavourable step	▼ 93%
Land & buildings	€ 174,811 Land & buildings 2022: € 174,811 First fiscal year in the series	€ 165,945 Land & buildings 2023: € 165,945 ▼ 5% vs 2022 (€ 174,811) Unchanged	€ 157,079 Land & buildings 2024: € 157,079 ▼ 5% vs 2023 (€ 165,945) Unchanged	€ 148,212 Land & buildings 2025: € 148,212 ▼ 6% vs 2024 (€ 157,079) Unchanged	▼ 6%
Retained profit	€ 52,655 Retained profit 2022: € 52,655 First fiscal year in the series	€ 58,841 Retained profit 2023: € 58,841 ▲ 12% vs 2022 (€ 52,655) Favourable step	€ 43,600 Retained profit 2024: € 43,600 ▼ 26% vs 2023 (€ 58,841) Unfavourable step	€ 46,935 Retained profit 2025: € 46,935 ▲ 8% vs 2024 (€ 43,600) Favourable step	▲ 8%
Dividend	€ 3,000 Dividend 2022: € 3,000 First fiscal year in the series	€ 833 Dividend 2023: € 833 ▼ 72% vs 2022 (€ 3,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 833) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 203,039 Bank debt 2022: € 203,039 First fiscal year in the series	€ 188,183 Bank debt 2023: € 188,183 ▼ 7% vs 2022 (€ 203,039) Favourable step	€ 185,934 Bank debt 2024: € 185,934 ▼ 1% vs 2023 (€ 188,183) Favourable step	€ 159,876 Bank debt 2025: € 159,876 ▼ 14% vs 2024 (€ 185,934) Favourable step	▼ 14%
Balance sheet total	€ 321,638 Balance sheet total 2022: € 321,638 First fiscal year in the series	€ 314,296 Balance sheet total 2023: € 314,296 ▼ 2% vs 2022 (€ 321,638) Unchanged	€ 314,857 Balance sheet total 2024: € 314,857 Unchanged (€ 314,296) Unchanged	€ 260,753 Balance sheet total 2025: € 260,753 ▼ 17% vs 2024 (€ 314,857) Unchanged	▼ 17%

Key figures of PHARMACIE GONAY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE GONAY?

What happened at PHARMACIE GONAY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 3,335. Source: NBB ↗
Jan 1, 2008 New establishment in Liège. KBO
Dec 21, 2007 Start of the company according to the CBE. KBO

In short

From € 3,290 profit in 2022 to € 3,335 profit in 2025.

Paid € 5,320 in corporate taxes since 2022.

Best year ever: 2023, with € 7,019 profit.

Paid out € 3,833 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE GONAY? We notify you, reason included.

Follow PHARMACIE GONAY

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Sophie GONAY

PHARMACIE GONAY

Behind PHARMACIE GONAY is Sophie GONAY.

See the full network in the app

Directors

According to the 2025 annual accounts

Sophie GONAY

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Parc 5

4020 Liège

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0894.414.729
VAT number: BE 0894.414.729
Registered office: Rue du Parc 5, 4020 Liège
Names & denominations: PHARMACIE GONAY
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 21 December 2007
Peppol: Active · Active since 6 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗